Research has examined the mitochondrial glutathione pool (mGSH) and its role in protecting the organelle from reactive oxygen species generated during oxidative phosphorylation, with studies investigating mGSH depletion in models of mitochondrial dysfunction
High-Protein Diets and Muscle Retention During Weight Loss Pasiakos SM et al
Well-suited to research into GI health and reducing gut inflammation, this innovative blend may also have systemic healing effects
GLP-1, or Glucagon-like Peptide-1, is a hormone produced in the gut, specifically by the L cells of the small intestine and colon
As MBS leaderand Accomplish Health advisorJOHN MORTON puts it: Combining surgical approaches and GLP-1 receptor agonist therapy presents an opportunity to further improve outcomes for patients undergoing MBS. --- Review: Combining Medications With Bariatric Surgery to Treat Obesity To view or add a comment, sign in Compared with GLP-1 RAs, bariatric metabolic surgery was associated with lower rates of: All-cause mortality Major adverse cardiovascular events (MACE) Nephropathy Retinopathy These findings indicate that even with the availability of GLP-1 RAs, metabolic surgery remains superior to medical treatment for macrovascular and microvascular outcomes in patients with diabetes and obesity
